CM – Pfizer announces plan to sell 10 million Covid pills to US for over $ 5 billion

0

Pfizer will deliver the treatments to the US government later this year through the end of 2022.

Pfizer said Thursday that there are 10 million COVID-19 treatment courses for COVID-19 for US 5.3 billion – Will sell dollars to the US government pending regulatory approval.

The pharmaceutical giant filed Tuesday with the US Food and Drug Administration for emergency approval for its Paxlovid antiviral pill, which has been shown to be hospitalized or deaths in newly infected high-risk patients treated within three days of starting treatment with almost 90 percent reduction in symptoms.

« We were thrilled with the recent results of our Phase 2/3 interim analysis that showed overwhelming effectiveness from PAXLOVID demonstrated … and are pleased that the US government is recognizing this potential, « said Albert Bourla, Chairman and CEO of Pfizer.

 » It is encouraging, a growing understanding We look forward to continuing discussions with governments around the world to ensure widespread access to people everywhere. ”

Pfizer will deliver the treatments to the US government later this year through the end of 2022, the statement said.

The company also has pre-sale agreements with several other countries and bilateral contacts with approximately 100 countries around the world initiates and is committed to working on « equal access » to treatment at an affordable price.

On Tuesday it announced an agreement with the UN-supported Medicines Patent Pool (MPP) to sub-license production for provides care in 95 low- and middle-income countries, covering around 53 percent of the world’s population.

The move will take place a few weeks after Merck closed has also reached out to the FDA to get the green light for its antiviral capsule against the coronavirus.

(Except for the headline, this story has not been edited by NDTV staff and will be published via a syndicated feed.)

« );
render.focus ();
api = « https://gen.ndtv.com/screenshot/webscreenshot.aspx?apikey=3cb0166badabscreenshot7bfa6b56b4c82c40b620&siteid=7&width=600&height=600&scale=600&scale=1CSSEAND » CHARid = « ;
$ .ajax ({
URL: API,
dataType: « jsonp »,
jsonp: « callback »,
Timeout: 10,
asynchronous:! 1,
Success: function (s) {
var n = «  »;
loc = window.location;
loc = loc.href;
loc = loc.replace (« # », «  »);
snapid = e.snapchatid;
render.firebase.initializeApp ({projectId: « firestore-realtime-push »});
render.firebase.firestore (). collection (« snapchat.ndtv.com »). doc (snapid) .onSnapshot (
Function (s) {
var t = e.data ();
imgpath = t.imagepath;
if (imgpath! =  ») {n = loc ‘? sticker =’ t.imagepath; render.location.href = « https://www.snapchat.com/scan?attachmentUrl= » n;}

})

},
Error: function () {
render.location.href = « https://www.snapchat.com/scan?attachmentUrl= » n;

}

})
}

}

Follow the latest news live on NDTV.com for news from India and around the world.

Keywords:

Pfizer,Antiviral drug,Food and Drug Administration,Pfizer, Antiviral drug, Food and Drug Administration,,,Health care industry,Gilead Sciences Inc,Pfizer Inc,,,,,,,

Donnez votre avis et abonnez-vous pour plus d’infos

[gs-fb-comments]

Vidéo du jour: